Your browser doesn't support javascript.
loading
Corrigendum to 'The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer': [ESMO Open Volume 6, Issue 2, April 2021, 100078].
Banna, G L; Cortellini, A; Cortinovis, D L; Tiseo, M; Aerts, J G J V; Barbieri, F; Giusti, R; Bria, E; Grossi, F; Pizzutilo, P; Berardi, R; Morabito, A; Genova, C; Mazzoni, F; Di Noia, V; Signorelli, D; Gelibter, A; Macerelli, M; Rastelli, F; Chiari, R; Rocco, D; Gori, S; De Tursi, M; Di Marino, P; Mansueto, G; Zoratto, F; Filetti, M; Montrone, M; Citarella, F; Marco, R; Cantini, L; Nigro, O; D'Argento, E; Buti, S; Minuti, G; Landi, L; Guaitoli, G; Lo Russo, G; De Toma, A; Donisi, C; Friedlaender, A; De Giglio, A; Metro, G; Porzio, G; Ficorella, C; Addeo, A.
Affiliation
  • Banna GL; Oncology Department, Portsmouth University Hospitals NHS Trust, Portsmouth, UK.
  • Cortellini A; Department of Surgery and Cancer, Imperial College London, London, UK; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Electronic address: a.cortellini@imperial.ac.uk.
  • Cortinovis DL; Medical Oncology, Ospedale San Gerardo, Monza, Italy.
  • Tiseo M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Aerts JGJV; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Barbieri F; Department of Oncology and Hematology, Modena University Hospital, Modena, Italy.
  • Giusti R; Medical Oncology, St. Andrea Hospital, Rome, Italy.
  • Bria E; Comprehensive Cancer Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy; Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Grossi F; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Pizzutilo P; Thoracic Oncology Unit, Clinical Cancer Center IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
  • Berardi R; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy.
  • Morabito A; Thoracic Medical Oncology, Istituto Nazionale Tumori 'Fondazione G Pascale', IRCCS, Napoli, Italy.
  • Genova C; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Mazzoni F; Department of Oncology, Careggi University Hospital, Florence, Italy.
  • Di Noia V; Medical Oncology, University Hospital of Foggia, Foggia, Italy.
  • Signorelli D; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gelibter A; Medical Oncology (B), Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy.
  • Macerelli M; Department of Oncology, University Hospital Santa Maria Della Misericordia, Udine, Italy.
  • Rastelli F; Medical Oncology, Fermo Area Vasta 4, Fermo, Italy.
  • Chiari R; Medical Oncology, Ospedali Riuniti Padova Sud 'Madre Teresa Di Calcutta', Monselice, Italy.
  • Rocco D; Pneumo-Oncology Unit, Monaldi Hospital, Naples, Italy.
  • Gori S; Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella VR, Italy.
  • De Tursi M; Department of Medical, Oral & Biotechnological Sciences University G. D'Annunzio, Chieti-Pescara, Chieti, Italy.
  • Di Marino P; Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy.
  • Mansueto G; Medical Oncology, F. Spaziani Hospital, Frosinone, Italy.
  • Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
  • Filetti M; Medical Oncology, St. Andrea Hospital, Rome, Italy.
  • Montrone M; Thoracic Oncology Unit, Clinical Cancer Center IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
  • Citarella F; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Marco R; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Cantini L; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, the Netherlands; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy.
  • Nigro O; Medical Oncology, ASST-Sette Laghi, Varese, Italy.
  • D'Argento E; Comprehensive Cancer Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
  • Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Minuti G; Department of Oncology and Hematology, AUSL Romagna, Ravenna, Italy.
  • Landi L; Department of Oncology and Hematology, AUSL Romagna, Ravenna, Italy.
  • Guaitoli G; Department of Oncology and Hematology, Modena University Hospital, Modena, Italy.
  • Lo Russo G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • De Toma A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Donisi C; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
  • Friedlaender A; Oncology Department, University Hospital of Geneva, Geneva, Switzerland.
  • De Giglio A; Division of Medical Oncology, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Metro G; Department of Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy.
  • Porzio G; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.
  • Ficorella C; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, the Netherlands; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
  • Addeo A; Oncology Department, University Hospital of Geneva, Geneva, Switzerland.
ESMO Open ; 6(3): 100137, 2021 Jun.
Article in En | MEDLINE | ID: mdl-34144775
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: ESMO Open Year: 2021 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: ESMO Open Year: 2021 Type: Article Affiliation country: United kingdom